28
Participants
Start Date
September 30, 2012
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
Dalantercept
Given SC
Laboratory Biomarker Analysis
Correlative studies
Memorial Sloan-Kettering Cancer Center, New York
Christiana Care Health System-Christiana Hospital, Newark
Beebe Medical Center, Lewes
Union Hospital of Cecil County, Elkton
Wake Forest University Health Sciences, Winston-Salem
Carolinas Medical Center/Levine Cancer Institute, Charlotte
Novant Health Presbyterian Medical Center, Charlotte
Florida Hospital Orlando, Orlando
Sarasota Memorial Hospital, Sarasota
Lake University Ireland Cancer Center, Mentor
Case Western Reserve University, Cleveland
Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
Hillcrest Hospital Cancer Center, Mayfield Heights
Cleveland Clinic Foundation, Cleveland
Saint Vincent Hospital and Health Care Center, Indianapolis
Sanford Cancer Center-Oncology Clinic, Sioux Falls
Sanford NCI Community Oncology Research Program of the North Central Plains, Sioux Falls
University of Chicago Comprehensive Cancer Center, Chicago
Decatur Memorial Hospital, Decatur
Washington University School of Medicine, St Louis
Nebraska Methodist Hospital, Omaha
University of Oklahoma Health Sciences Center, Oklahoma City
UCSF Medical Center-Mount Zion, San Francisco
Pacific Gynecology Specialists, Seattle
Seattle Cancer Care Alliance, Seattle
Northwest Hospital, Seattle
University of Washington Medical Center, Seattle
Maine Medical Center-Bramhall Campus, Portland
Women and Infants Hospital, Providence
Sanford USD Medical Center - Sioux Falls, Sioux Falls
National Cancer Institute (NCI)
NIH
Gynecologic Oncology Group
NETWORK